UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 43 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 100 | -99.8% | 0.00% | -100.0% |
| Q3 2020 | $210,000 | +20900.0% | 60,900 | +30350.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | -94.4% | 200 | -93.3% | 0.00% | – |
| Q3 2019 | $18,000 | +28.6% | 3,000 | +100.0% | 0.00% | – |
| Q2 2019 | $14,000 | +16.7% | 1,500 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | -50.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2018 | $24,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q3 2018 | $24,000 | +9.1% | 1,500 | 0.0% | 0.00% | – |
| Q2 2018 | $22,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $9,431,886,000 | 10.86% |
| Invus Financial Advisors, LLC | 1,094,998 | $6,570,000 | 1.51% |
| Founders Fund V Management, LLC | 491,751 | $2,951,000 | 0.16% |
| Arbor Wealth Management, LLC | 25,888 | $155,000 | 0.05% |
| PDT Partners, LLC | 70,233 | $421,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 575,443 | $3,453,000 | 0.03% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 18,644 | $112,000 | 0.02% |
| Fort Point Capital Partners LLC | 10,000 | $60,000 | 0.01% |
| Baillie Gifford | 3,803,014 | $22,818,000 | 0.01% |
| Summit Trail Advisors, LLC | 13,458 | $81,000 | 0.01% |